Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
31
10
2019
accepted:
19
08
2020
entrez:
11
9
2020
pubmed:
12
9
2020
medline:
28
10
2020
Statut:
epublish
Résumé
Ageing populations and rising prevalence of non-communicable diseases (NCDs) increasingly contribute to the growing cost burden facing European healthcare systems. Few studies have attempted to quantify the future magnitude of this burden at the European level, and none of them consider the impact of potential changes in risk factor trajectories on future health expenditures. The new microsimulation model forecasts the impact of behavioural and metabolic risk factors on NCDs, longevity and direct healthcare costs, and shows how changes in epidemiological trends can modify those impacts. Economic burden of NCDs is modelled under three scenarios based on assumed future risk factors trends: business as usual (BAU); best case and worst case predictions (BCP and WCP). The direct costs of NCDs in the EU 27 countries and the UK (in constant 2014 prices) will grow under all scenarios. Between 2014 and 2050, the overall healthcare spending is expected to increase by 0.8% annually under BAU. In the all the countries, 605 billion Euros can be saved by 2050 if BCP is realized compared to the BAU, while excess spending under the WCP is forecast to be around 350 billion. Interpretation: Although the savings realised under the BCP can be substantial, population ageing is a stronger driver of rising total healthcare expenditures in Europe compared to scenario-based changes in risk factor prevalence.
Sections du résumé
BACKGROUND
Ageing populations and rising prevalence of non-communicable diseases (NCDs) increasingly contribute to the growing cost burden facing European healthcare systems. Few studies have attempted to quantify the future magnitude of this burden at the European level, and none of them consider the impact of potential changes in risk factor trajectories on future health expenditures.
METHODS
The new microsimulation model forecasts the impact of behavioural and metabolic risk factors on NCDs, longevity and direct healthcare costs, and shows how changes in epidemiological trends can modify those impacts. Economic burden of NCDs is modelled under three scenarios based on assumed future risk factors trends: business as usual (BAU); best case and worst case predictions (BCP and WCP).
FINDINGS
The direct costs of NCDs in the EU 27 countries and the UK (in constant 2014 prices) will grow under all scenarios. Between 2014 and 2050, the overall healthcare spending is expected to increase by 0.8% annually under BAU. In the all the countries, 605 billion Euros can be saved by 2050 if BCP is realized compared to the BAU, while excess spending under the WCP is forecast to be around 350 billion. Interpretation: Although the savings realised under the BCP can be substantial, population ageing is a stronger driver of rising total healthcare expenditures in Europe compared to scenario-based changes in risk factor prevalence.
Identifiants
pubmed: 32915826
doi: 10.1371/journal.pone.0238565
pii: PONE-D-19-30345
pmc: PMC7485835
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0238565Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2018 Aug 9;13(8):e0201697
pubmed: 30091998
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Lancet. 2005 Oct 29-Nov 4;366(9496):1514
pubmed: 16257331
Lancet. 2018 May 5;391(10132):1783-1798
pubmed: 29678341
Int J Health Plann Manage. 2011 Jul-Sep;26(3):246-63
pubmed: 20939027
Health Aff (Millwood). 2009 Jan-Feb;28(1):42-5
pubmed: 19124852
Lancet. 2010 Nov 20;376(9754):1775-84
pubmed: 21074255
BMC Med. 2017 Dec 08;15(1):216
pubmed: 29221453
Obes Rev. 2006 Aug;7(3):271-93
pubmed: 16866975
Adv Appl Stat. 2014 Oct;42(2):95-117
pubmed: 26097294
Am Econ Rev. 1987 Jun;77(3):251-77
pubmed: 10284091
Health Aff (Millwood). 2005;24 Suppl 2:W5R5-17
pubmed: 16186147
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Lancet. 2011 Aug 27;378(9793):815-25
pubmed: 21872750
BMC Public Health. 2017 Jul 21;18(1):43
pubmed: 28732487
Soc Sci Med. 2015 May;133:67-76
pubmed: 25841097
Soc Sci Med. 2006 Apr;62(7):1768-84
pubmed: 16226363
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
PLoS One. 2020 Apr 29;15(4):e0231725
pubmed: 32348352
J Occup Environ Med. 2010 Oct;52(10):971-6
pubmed: 20881629
Lancet. 2018 May 19;391(10134):1973-1974
pubmed: 29627165
BMC Public Health. 2013 Oct 30;13:1030
pubmed: 24172142
Lancet. 2007 Dec 8;370(9603):1929-38
pubmed: 18063029
Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31
pubmed: 19635784